강박증 환자의 인지행동치료 순응도에영향을 미치는 요인에 관한 연구

키워드

참고문헌 (37)

1. American Psychiatry Association, "Diagnostic and Statistical Manual of Mental Disorders" (1995), American Psychiatry Association
2. Horwath E, "The epidemiology and cross-national presentation of obsessive-compulsive disorder", Psychiatr Clin North Am, 23, pp.493~507 (2000)
3. Goodman WK, "Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo", Arch Gen Psychiatry, 46, pp.36~44 (1989)
4. Anand N, "Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study", J Anxiety Disord, 25, pp.939~945 (2011)
5. Abramowitz JS, "The psychological treatment of obsessive-compulsive disorder", Can J Psychiatry, 51, pp.407~416 (2006)
6. Foa EB, "Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder", Am J Psychiatry, 162, pp.151~161 (2005)
7. Mancebo MC, "Development of the Treatment Adherence Survey-patient version (TAS-P) for OCD", J Anxiety Disord, 22, pp.32~43 (2008)
8. Mancebo MC, "The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement", J Clin Psychiatry, 67, pp.1713~1720 (2006)
9. Belotto-Silva C, "Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial", J Anxiety Disord, 26, pp.25~31 (2012)
10. Simpson HB, "Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder", J Consult Clin Psychol, 79, pp.247~252 (2011)
11. Diniz JB, "Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder", Clinics, 66, pp.387~393 (2011)
12. Mancebo MC, "Patient utilization of cognitive-behavioral therapy for OCD", Behav Ther, 42, pp.399~412 (2011)
13. First MB, "Structured Clinical Interview for DSM-IV Axis I disorder" (1996), New York Psychiatric Institute
14. First MB, "Nosology of chronic mood disorders", Psychiatr Clin North Am, 19, pp.29~39 (1996)
15. Jónsson H, "Group cognitive behavioural therapy for obsessive- compulsive disorder: a systematic review and meta-analysis", Acta Psychiatr Scand, 119, pp.98~106 (2009)
16. Goodman WK, "The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability", Arch Gen Psychiatry, 46, pp.1006~1011 (1989)
17. Steer RA, "Structure of the computer- assisted Beck Anxiety Inventory with psychiatric inpatients", J Pers Assess, 60, pp.532~542 (1993)
18. Gorenstein C, "Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects", Braz J Med Biol Res, 29, pp.453~457 (1996)
19. Kozak MJ, "Mastery of obsessive compulsive disorder : A Cognitive-Behavioral Approach" (1997), Therapy Works, Inc
20. Rachman S, "Perceived responsibility: structure and significance", Behav Res Ther, 33, pp.779~784 (1995)
21. Salkovskis PM, "Cognitive therapy of obsessive-compulsive disorder: treating treatment failures", Behav Psychother, 13, pp.243~255 (1985)
22. Salkovskis PM, "Understanding and treating obsessive-compulsive disorder", Behav Res Ther, 37(1), pp.29~52 (1999)
23. Guy W, "Clinical Global Impressions (CGI) scale, In Handbook of psychiatric measures", pp.90~92 (2010), American Psychiatric Publishing
24. Rosario-Campos MC, "The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions", Mol Psychiatry, 11, pp.495~504 (2006)
25. Jaurrieta N, "Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: follow up", Psychiatry Clin Neurosci, 62, pp.697~704 (2008)
26. Lippens T, "Treatment satisfaction, perceived treatment effectiveness, and dropout among older users of mental health services", J Clin Psychol, 67, pp.1197~1209 (2011)
27. Santana L, "Rates and correlates of nonadherence to treatment in obsessive-compulsive disorder", J Psychiatr Pract, 19, pp.42~53 (2013)
28. Anand N, "Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study", J Anxiety Disord, 25, pp.939~945 (2011)
29. Maher MJ, "Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder", Psychol Med, 40, pp.2013~2023 (2010)
30. Prasko J, "Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder", Neuro Endocrinol Lett, 30, pp.615~623 (2009)
31. Simpson HB, "Combining pharmacotherapy and cognitive- behavioral therapy in the treatment of OCD, In Concepts and Controversies in Obsessive- Compulsive Disorder", pp.359~376 (2005), Springer
32. Franklin ME, "Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples", J Consult Clin Psychol, 68, pp.594~602 (2000)
33. Gava I, "Psychological treatments versus treatment as usual for obsessive compulsive disorder", Cochrane Database Syst Rev, 2, pp.005333~ (2007)
34. Anholt GE, "The impact of depression on the treatment of obsessivecompulsive disorder: results from a 5-year follow-up", J Affect Disord, 135, pp.201~207 (2011)
35. Andouz Z, "The efficacy of metacognitive therapy on patients suffering from pure obsession", Iran J Psychiatry, 7, pp.11~21 (2012)
36. Maher MJ, "Predictors of patient adherence to cognitive-behavioral therapy for obsessive-compulsive disorder", Psychother Psychosom, 81, pp.124~126 (2012)
37. Eskildsen A, "Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review", Nord J Psychiatry, 64, pp.94~105 (2010)

관련 논문AI추천